COMPANY
Clinical Phase 1
Keywords: oncology immunology infectious disease disease by infectious agent vaccine RBI-4000
Location: San Diego, CA · source · Oct 13, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: A Study of RBI-4000 in Healthy Participants source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06048770 | A Study of RBI-4000 in Healthy Participants | Phase 1 | Terminated | Sep 1, 2023 | Jul 31, 2024 (actual) |
